PCV22 COST-EFFECTIVENESS ANALYSIS OF OLMESARTAN/AMLODIPINE FIX-DOSE COMBINATION FOR HYPERTENSIVE PATIENTS IN CHINA
Abstract
Authors
J. Xuan Y. Lu D. Xuan Y. Fu
J. Xuan Y. Lu D. Xuan Y. Fu
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now